BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2555447)

  • 1. Combined effects of acyclovir and human interferon-alpha on herpes simplex virus replication in cultured neural cells.
    Hanada N; Kido S; Kuzushima K; Goto Y; Rahman MM; Morishima T
    J Med Virol; 1989 Sep; 29(1):7-12. PubMed ID: 2555447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.
    Scheck AC; Wigdahl B; De Clercq E; Rapp F
    Antimicrob Agents Chemother; 1986 Apr; 29(4):589-93. PubMed ID: 3010847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukoregulin, a novel cytokine enhances the anti-herpesvirus actions of acyclovir.
    Hooks JJ; Detrick B; Evans CH
    Clin Immunol Immunopathol; 1991 Aug; 60(2):244-53. PubMed ID: 1649027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
    Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA
    Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
    Naito T; Shiota H; Nitta K; Mimura Y
    Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two methods in the determination of the sensitivity of 84 herpes simplex virus (HSV) type 1 and 2 clinical isolates to acyclovir and alpha-interferon.
    Brisebois JJ; Dumas VM; Joncas JH
    Antiviral Res; 1989 Mar; 11(2):67-75. PubMed ID: 2543287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir.
    Harmenberg J; Wahren B
    Intervirology; 1982; 17(4):215-21. PubMed ID: 6290415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between recombinant human interferon and nucleoside antiviral agents against herpes simplex virus: examination with an automated microtiter plate assay.
    Moran DM; Kern ER; Overall JC
    J Infect Dis; 1985 Jun; 151(6):1116-22. PubMed ID: 2987369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
    Reefschläger J; Wutzler P; Thiel KD; Herrmann G
    Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
    Taylor JL; Casey MS; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.
    Hayashi K; Iinuma M; Sasaki K; Hayashi T
    Arch Virol; 2012 Aug; 157(8):1489-98. PubMed ID: 22580497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase.
    Taylor JL; Tom P; O'Brien WJ
    Antiviral Res; 1998 May; 38(2):95-106. PubMed ID: 9707372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
    Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
    BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the multiplication of human herpes virus I by prostaglandin D2 and the synergistic effect of human leukocyte interferon].
    Imanishi J; Tanaka A; Matsuoka H
    C R Seances Soc Biol Fil; 1984; 178(6):671-4. PubMed ID: 6100083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
    Eppstein DA; Marsh YV
    Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages.
    Domke-Opitz I; Straub P; Kirchner H
    J Virol; 1986 Oct; 60(1):37-42. PubMed ID: 3018299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced replication of herpes simplex virus by hexamethylene bisacetamide.
    Yura Y; Kondo Y; Iga H; Harada K; Tujimoto H; Yanagawa T; Yoshida H; Sato M
    J Natl Cancer Inst; 1991 Feb; 83(3):186-9. PubMed ID: 1846430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.